Hotline: +86-18022463983    020-85206863

Antibody Discovery Platforms - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: 2024-12-04   |   Pages: 126   |   Tables: 215   |  Medical Care

The global market for Antibody Discovery Platforms was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Antibody Discovery Platforms was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Antibody Discovery Platforms was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Antibody Discovery Platforms was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Antibody Discovery Platforms include Abwiz Bio, Aragen Bioscience, Creative Biolabs, Distributed Bio, ImmunoPrecise Antibodies, Integral Molecular, LakePharma, Syd Labs and Abzena, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Antibody Discovery Platforms, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Antibody Discovery Platforms by region & country, by Type, and by Application.
The Antibody Discovery Platforms market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody Discovery Platforms.
Market Segmentation
By Company
Abwiz Bio
Aragen Bioscience
Creative Biolabs
Distributed Bio
ImmunoPrecise Antibodies
Integral Molecular
LakePharma
Syd Labs
Abzena
BIOTEM
PX'Therapeutics
ChemPartner
HD Biosciences
Viva Biotech
WuXi Biologics
Kymab
Ligand Pharmaceuticals
MorphoSys
Segment by Type:
Antigen Designing
Hit Generation
Lead Selection
Lead Optimization
Lead Characterization
Others
Segment by Application
Pharmaceutical
Institute of Biology
Therapeutic Research
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Antibody Discovery Platforms manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Antibody Discovery Platforms in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Antibody Discovery Platforms in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Research Methodology

The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:


Stage 1 SECONDARY RESEARCH

The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.

 

Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES

After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.

 

Stage 3 ANALYSIS OF THE GATHERED DATA

The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.

 

Stage 4 QUANTITATIVE DATA

The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.

 

Stage 5 QUALITY CONTROL

Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.

 

1 Market Overview
1.1 Antibody Discovery Platforms Product Introduction
1.2 Global Antibody Discovery Platforms Market Size Forecast
1.3 Antibody Discovery Platforms Market Trends & Drivers
1.3.1 Antibody Discovery Platforms Industry Trends
1.3.2 Antibody Discovery Platforms Market Drivers & Opportunity
1.3.3 Antibody Discovery Platforms Market Challenges
1.3.4 Antibody Discovery Platforms Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Antibody Discovery Platforms Players Revenue Ranking (2023)
2.2 Global Antibody Discovery Platforms Revenue by Company (2019-2024)
2.3 Key Companies Antibody Discovery Platforms Manufacturing Base Distribution and Headquarters
2.4 Key Companies Antibody Discovery Platforms Product Offered
2.5 Key Companies Time to Begin Mass Production of Antibody Discovery Platforms
2.6 Antibody Discovery Platforms Market Competitive Analysis
2.6.1 Antibody Discovery Platforms Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Antibody Discovery Platforms Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Discovery Platforms as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Antigen Designing
3.1.2 Hit Generation
3.1.3 Lead Selection
3.1.4 Lead Optimization
3.1.5 Lead Characterization
3.1.6 Others
3.2 Global Antibody Discovery Platforms Sales Value by Type
3.2.1 Global Antibody Discovery Platforms Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Antibody Discovery Platforms Sales Value, by Type (2019-2030)
3.2.3 Global Antibody Discovery Platforms Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical
4.1.2 Institute of Biology
4.1.3 Therapeutic Research
4.1.4 Others
4.2 Global Antibody Discovery Platforms Sales Value by Application
4.2.1 Global Antibody Discovery Platforms Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Antibody Discovery Platforms Sales Value, by Application (2019-2030)
4.2.3 Global Antibody Discovery Platforms Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Antibody Discovery Platforms Sales Value by Region
5.1.1 Global Antibody Discovery Platforms Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Antibody Discovery Platforms Sales Value by Region (2019-2024)
5.1.3 Global Antibody Discovery Platforms Sales Value by Region (2025-2030)
5.1.4 Global Antibody Discovery Platforms Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Antibody Discovery Platforms Sales Value, 2019-2030
5.2.2 North America Antibody Discovery Platforms Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Antibody Discovery Platforms Sales Value, 2019-2030
5.3.2 Europe Antibody Discovery Platforms Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Antibody Discovery Platforms Sales Value, 2019-2030
5.4.2 Asia Pacific Antibody Discovery Platforms Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Antibody Discovery Platforms Sales Value, 2019-2030
5.5.2 South America Antibody Discovery Platforms Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Antibody Discovery Platforms Sales Value, 2019-2030
5.6.2 Middle East & Africa Antibody Discovery Platforms Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Antibody Discovery Platforms Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Antibody Discovery Platforms Sales Value
6.3 United States
6.3.1 United States Antibody Discovery Platforms Sales Value, 2019-2030
6.3.2 United States Antibody Discovery Platforms Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Antibody Discovery Platforms Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Antibody Discovery Platforms Sales Value, 2019-2030
6.4.2 Europe Antibody Discovery Platforms Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Antibody Discovery Platforms Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Antibody Discovery Platforms Sales Value, 2019-2030
6.5.2 China Antibody Discovery Platforms Sales Value by Type (%), 2023 VS 2030
6.5.3 China Antibody Discovery Platforms Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Antibody Discovery Platforms Sales Value, 2019-2030
6.6.2 Japan Antibody Discovery Platforms Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Antibody Discovery Platforms Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Antibody Discovery Platforms Sales Value, 2019-2030
6.7.2 South Korea Antibody Discovery Platforms Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Antibody Discovery Platforms Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Antibody Discovery Platforms Sales Value, 2019-2030
6.8.2 Southeast Asia Antibody Discovery Platforms Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Antibody Discovery Platforms Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Antibody Discovery Platforms Sales Value, 2019-2030
6.9.2 India Antibody Discovery Platforms Sales Value by Type (%), 2023 VS 2030
6.9.3 India Antibody Discovery Platforms Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abwiz Bio
7.1.1 Abwiz Bio Profile
7.1.2 Abwiz Bio Main Business
7.1.3 Abwiz Bio Antibody Discovery Platforms Products, Services and Solutions
7.1.4 Abwiz Bio Antibody Discovery Platforms Revenue (US$ Million) & (2019-2024)
7.1.5 Abwiz Bio Recent Developments
7.2 Aragen Bioscience
7.2.1 Aragen Bioscience Profile
7.2.2 Aragen Bioscience Main Business
7.2.3 Aragen Bioscience Antibody Discovery Platforms Products, Services and Solutions
7.2.4 Aragen Bioscience Antibody Discovery Platforms Revenue (US$ Million) & (2019-2024)
7.2.5 Aragen Bioscience Recent Developments
7.3 Creative Biolabs
7.3.1 Creative Biolabs Profile
7.3.2 Creative Biolabs Main Business
7.3.3 Creative Biolabs Antibody Discovery Platforms Products, Services and Solutions
7.3.4 Creative Biolabs Antibody Discovery Platforms Revenue (US$ Million) & (2019-2024)
7.3.5 Distributed Bio Recent Developments
7.4 Distributed Bio
7.4.1 Distributed Bio Profile
7.4.2 Distributed Bio Main Business
7.4.3 Distributed Bio Antibody Discovery Platforms Products, Services and Solutions
7.4.4 Distributed Bio Antibody Discovery Platforms Revenue (US$ Million) & (2019-2024)
7.4.5 Distributed Bio Recent Developments
7.5 ImmunoPrecise Antibodies
7.5.1 ImmunoPrecise Antibodies Profile
7.5.2 ImmunoPrecise Antibodies Main Business
7.5.3 ImmunoPrecise Antibodies Antibody Discovery Platforms Products, Services and Solutions
7.5.4 ImmunoPrecise Antibodies Antibody Discovery Platforms Revenue (US$ Million) & (2019-2024)
7.5.5 ImmunoPrecise Antibodies Recent Developments
7.6 Integral Molecular
7.6.1 Integral Molecular Profile
7.6.2 Integral Molecular Main Business
7.6.3 Integral Molecular Antibody Discovery Platforms Products, Services and Solutions
7.6.4 Integral Molecular Antibody Discovery Platforms Revenue (US$ Million) & (2019-2024)
7.6.5 Integral Molecular Recent Developments
7.7 LakePharma
7.7.1 LakePharma Profile
7.7.2 LakePharma Main Business
7.7.3 LakePharma Antibody Discovery Platforms Products, Services and Solutions
7.7.4 LakePharma Antibody Discovery Platforms Revenue (US$ Million) & (2019-2024)
7.7.5 LakePharma Recent Developments
7.8 Syd Labs
7.8.1 Syd Labs Profile
7.8.2 Syd Labs Main Business
7.8.3 Syd Labs Antibody Discovery Platforms Products, Services and Solutions
7.8.4 Syd Labs Antibody Discovery Platforms Revenue (US$ Million) & (2019-2024)
7.8.5 Syd Labs Recent Developments
7.9 Abzena
7.9.1 Abzena Profile
7.9.2 Abzena Main Business
7.9.3 Abzena Antibody Discovery Platforms Products, Services and Solutions
7.9.4 Abzena Antibody Discovery Platforms Revenue (US$ Million) & (2019-2024)
7.9.5 Abzena Recent Developments
7.10 BIOTEM
7.10.1 BIOTEM Profile
7.10.2 BIOTEM Main Business
7.10.3 BIOTEM Antibody Discovery Platforms Products, Services and Solutions
7.10.4 BIOTEM Antibody Discovery Platforms Revenue (US$ Million) & (2019-2024)
7.10.5 BIOTEM Recent Developments
7.11 PX'Therapeutics
7.11.1 PX'Therapeutics Profile
7.11.2 PX'Therapeutics Main Business
7.11.3 PX'Therapeutics Antibody Discovery Platforms Products, Services and Solutions
7.11.4 PX'Therapeutics Antibody Discovery Platforms Revenue (US$ Million) & (2019-2024)
7.11.5 PX'Therapeutics Recent Developments
7.12 ChemPartner
7.12.1 ChemPartner Profile
7.12.2 ChemPartner Main Business
7.12.3 ChemPartner Antibody Discovery Platforms Products, Services and Solutions
7.12.4 ChemPartner Antibody Discovery Platforms Revenue (US$ Million) & (2019-2024)
7.12.5 ChemPartner Recent Developments
7.13 HD Biosciences
7.13.1 HD Biosciences Profile
7.13.2 HD Biosciences Main Business
7.13.3 HD Biosciences Antibody Discovery Platforms Products, Services and Solutions
7.13.4 HD Biosciences Antibody Discovery Platforms Revenue (US$ Million) & (2019-2024)
7.13.5 HD Biosciences Recent Developments
7.14 Viva Biotech
7.14.1 Viva Biotech Profile
7.14.2 Viva Biotech Main Business
7.14.3 Viva Biotech Antibody Discovery Platforms Products, Services and Solutions
7.14.4 Viva Biotech Antibody Discovery Platforms Revenue (US$ Million) & (2019-2024)
7.14.5 Viva Biotech Recent Developments
7.15 WuXi Biologics
7.15.1 WuXi Biologics Profile
7.15.2 WuXi Biologics Main Business
7.15.3 WuXi Biologics Antibody Discovery Platforms Products, Services and Solutions
7.15.4 WuXi Biologics Antibody Discovery Platforms Revenue (US$ Million) & (2019-2024)
7.15.5 WuXi Biologics Recent Developments
7.16 Kymab
7.16.1 Kymab Profile
7.16.2 Kymab Main Business
7.16.3 Kymab Antibody Discovery Platforms Products, Services and Solutions
7.16.4 Kymab Antibody Discovery Platforms Revenue (US$ Million) & (2019-2024)
7.16.5 Kymab Recent Developments
7.17 Ligand Pharmaceuticals
7.17.1 Ligand Pharmaceuticals Profile
7.17.2 Ligand Pharmaceuticals Main Business
7.17.3 Ligand Pharmaceuticals Antibody Discovery Platforms Products, Services and Solutions
7.17.4 Ligand Pharmaceuticals Antibody Discovery Platforms Revenue (US$ Million) & (2019-2024)
7.17.5 Ligand Pharmaceuticals Recent Developments
7.18 MorphoSys
7.18.1 MorphoSys Profile
7.18.2 MorphoSys Main Business
7.18.3 MorphoSys Antibody Discovery Platforms Products, Services and Solutions
7.18.4 MorphoSys Antibody Discovery Platforms Revenue (US$ Million) & (2019-2024)
7.18.5 MorphoSys Recent Developments
8 Industry Chain Analysis
8.1 Antibody Discovery Platforms Industrial Chain
8.2 Antibody Discovery Platforms Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Antibody Discovery Platforms Sales Model
8.5.2 Sales Channel
8.5.3 Antibody Discovery Platforms Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

List of Tables
Table 1. Antibody Discovery Platforms Market Trends
Table 2. Antibody Discovery Platforms Market Drivers & Opportunity
Table 3. Antibody Discovery Platforms Market Challenges
Table 4. Antibody Discovery Platforms Market Restraints
Table 5. Global Antibody Discovery Platforms Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Antibody Discovery Platforms Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Antibody Discovery Platforms Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Antibody Discovery Platforms Product Type
Table 9. Key Companies Time to Begin Mass Production of Antibody Discovery Platforms
Table 10. Global Antibody Discovery Platforms Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Discovery Platforms as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Antibody Discovery Platforms Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Antibody Discovery Platforms Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Antibody Discovery Platforms Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Antibody Discovery Platforms Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Antibody Discovery Platforms Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Antibody Discovery Platforms Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Antibody Discovery Platforms Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Antibody Discovery Platforms Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Antibody Discovery Platforms Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Antibody Discovery Platforms Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Antibody Discovery Platforms Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Antibody Discovery Platforms Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Antibody Discovery Platforms Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Antibody Discovery Platforms Sales Value by Region (2019-2024) & (%)
Table 27. Global Antibody Discovery Platforms Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Antibody Discovery Platforms Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Antibody Discovery Platforms Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Antibody Discovery Platforms Sales Value, (2025-2030) & (US$ Million)
Table 31. Abwiz Bio Basic Information List
Table 32. Abwiz Bio Description and Business Overview
Table 33. Abwiz Bio Antibody Discovery Platforms Products, Services and Solutions
Table 34. Revenue (US$ Million) in Antibody Discovery Platforms Business of Abwiz Bio (2019-2024)
Table 35. Abwiz Bio Recent Developments
Table 36. Aragen Bioscience Basic Information List
Table 37. Aragen Bioscience Description and Business Overview
Table 38. Aragen Bioscience Antibody Discovery Platforms Products, Services and Solutions
Table 39. Revenue (US$ Million) in Antibody Discovery Platforms Business of Aragen Bioscience (2019-2024)
Table 40. Aragen Bioscience Recent Developments
Table 41. Creative Biolabs Basic Information List
Table 42. Creative Biolabs Description and Business Overview
Table 43. Creative Biolabs Antibody Discovery Platforms Products, Services and Solutions
Table 44. Revenue (US$ Million) in Antibody Discovery Platforms Business of Creative Biolabs (2019-2024)
Table 45. Creative Biolabs Recent Developments
Table 46. Distributed Bio Basic Information List
Table 47. Distributed Bio Description and Business Overview
Table 48. Distributed Bio Antibody Discovery Platforms Products, Services and Solutions
Table 49. Revenue (US$ Million) in Antibody Discovery Platforms Business of Distributed Bio (2019-2024)
Table 50. Distributed Bio Recent Developments
Table 51. ImmunoPrecise Antibodies Basic Information List
Table 52. ImmunoPrecise Antibodies Description and Business Overview
Table 53. ImmunoPrecise Antibodies Antibody Discovery Platforms Products, Services and Solutions
Table 54. Revenue (US$ Million) in Antibody Discovery Platforms Business of ImmunoPrecise Antibodies (2019-2024)
Table 55. ImmunoPrecise Antibodies Recent Developments
Table 56. Integral Molecular Basic Information List
Table 57. Integral Molecular Description and Business Overview
Table 58. Integral Molecular Antibody Discovery Platforms Products, Services and Solutions
Table 59. Revenue (US$ Million) in Antibody Discovery Platforms Business of Integral Molecular (2019-2024)
Table 60. Integral Molecular Recent Developments
Table 61. LakePharma Basic Information List
Table 62. LakePharma Description and Business Overview
Table 63. LakePharma Antibody Discovery Platforms Products, Services and Solutions
Table 64. Revenue (US$ Million) in Antibody Discovery Platforms Business of LakePharma (2019-2024)
Table 65. LakePharma Recent Developments
Table 66. Syd Labs Basic Information List
Table 67. Syd Labs Description and Business Overview
Table 68. Syd Labs Antibody Discovery Platforms Products, Services and Solutions
Table 69. Revenue (US$ Million) in Antibody Discovery Platforms Business of Syd Labs (2019-2024)
Table 70. Syd Labs Recent Developments
Table 71. Abzena Basic Information List
Table 72. Abzena Description and Business Overview
Table 73. Abzena Antibody Discovery Platforms Products, Services and Solutions
Table 74. Revenue (US$ Million) in Antibody Discovery Platforms Business of Abzena (2019-2024)
Table 75. Abzena Recent Developments
Table 76. BIOTEM Basic Information List
Table 77. BIOTEM Description and Business Overview
Table 78. BIOTEM Antibody Discovery Platforms Products, Services and Solutions
Table 79. Revenue (US$ Million) in Antibody Discovery Platforms Business of BIOTEM (2019-2024)
Table 80. BIOTEM Recent Developments
Table 81. PX'Therapeutics Basic Information List
Table 82. PX'Therapeutics Description and Business Overview
Table 83. PX'Therapeutics Antibody Discovery Platforms Products, Services and Solutions
Table 84. Revenue (US$ Million) in Antibody Discovery Platforms Business of PX'Therapeutics (2019-2024)
Table 85. PX'Therapeutics Recent Developments
Table 86. ChemPartner Basic Information List
Table 87. ChemPartner Description and Business Overview
Table 88. ChemPartner Antibody Discovery Platforms Products, Services and Solutions
Table 89. Revenue (US$ Million) in Antibody Discovery Platforms Business of ChemPartner (2019-2024)
Table 90. ChemPartner Recent Developments
Table 91. HD Biosciences Basic Information List
Table 92. HD Biosciences Description and Business Overview
Table 93. HD Biosciences Antibody Discovery Platforms Products, Services and Solutions
Table 94. Revenue (US$ Million) in Antibody Discovery Platforms Business of HD Biosciences (2019-2024)
Table 95. HD Biosciences Recent Developments
Table 96. Viva Biotech Basic Information List
Table 97. Viva Biotech Description and Business Overview
Table 98. Viva Biotech Antibody Discovery Platforms Products, Services and Solutions
Table 99. Revenue (US$ Million) in Antibody Discovery Platforms Business of Viva Biotech (2019-2024)
Table 100. Viva Biotech Recent Developments
Table 101. WuXi Biologics Basic Information List
Table 102. WuXi Biologics Description and Business Overview
Table 103. WuXi Biologics Antibody Discovery Platforms Products, Services and Solutions
Table 104. Revenue (US$ Million) in Antibody Discovery Platforms Business of WuXi Biologics (2019-2024)
Table 105. WuXi Biologics Recent Developments
Table 106. Kymab Basic Information List
Table 107. Kymab Description and Business Overview
Table 108. Kymab Antibody Discovery Platforms Products, Services and Solutions
Table 109. Revenue (US$ Million) in Antibody Discovery Platforms Business of Kymab (2019-2024)
Table 110. Kymab Recent Developments
Table 111. Ligand Pharmaceuticals Basic Information List
Table 112. Ligand Pharmaceuticals Description and Business Overview
Table 113. Ligand Pharmaceuticals Antibody Discovery Platforms Products, Services and Solutions
Table 114. Revenue (US$ Million) in Antibody Discovery Platforms Business of Ligand Pharmaceuticals (2019-2024)
Table 115. Ligand Pharmaceuticals Recent Developments
Table 116. MorphoSys Basic Information List
Table 117. MorphoSys Description and Business Overview
Table 118. MorphoSys Antibody Discovery Platforms Products, Services and Solutions
Table 119. Revenue (US$ Million) in Antibody Discovery Platforms Business of MorphoSys (2019-2024)
Table 120. MorphoSys Recent Developments
Table 121. Key Raw Materials Lists
Table 122. Raw Materials Key Suppliers Lists
Table 123. Antibody Discovery Platforms Downstream Customers
Table 124. Antibody Discovery Platforms Distributors List
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
Table 128. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Antibody Discovery Platforms Product Picture
Figure 2. Global Antibody Discovery Platforms Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Antibody Discovery Platforms Sales Value (2019-2030) & (US$ Million)
Figure 4. Antibody Discovery Platforms Report Years Considered
Figure 5. Global Antibody Discovery Platforms Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Antibody Discovery Platforms Revenue in 2023
Figure 7. Antibody Discovery Platforms Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Antigen Designing Picture
Figure 9. Hit Generation Picture
Figure 10. Lead Selection Picture
Figure 11. Lead Optimization Picture
Figure 12. Lead Characterization Picture
Figure 13. Others Picture
Figure 14. Global Antibody Discovery Platforms Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Antibody Discovery Platforms Sales Value Market Share by Type, 2023 & 2030
Figure 16. Product Picture of Pharmaceutical
Figure 17. Product Picture of Institute of Biology
Figure 18. Product Picture of Therapeutic Research
Figure 19. Product Picture of Others
Figure 20. Global Antibody Discovery Platforms Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Antibody Discovery Platforms Sales Value Market Share by Application, 2023 & 2030
Figure 22. North America Antibody Discovery Platforms Sales Value (2019-2030) & (US$ Million)
Figure 23. North America Antibody Discovery Platforms Sales Value by Country (%), 2023 VS 2030
Figure 24. Europe Antibody Discovery Platforms Sales Value (2019-2030) & (US$ Million)
Figure 25. Europe Antibody Discovery Platforms Sales Value by Country (%), 2023 VS 2030
Figure 26. Asia Pacific Antibody Discovery Platforms Sales Value (2019-2030) & (US$ Million)
Figure 27. Asia Pacific Antibody Discovery Platforms Sales Value by Country (%), 2023 VS 2030
Figure 28. South America Antibody Discovery Platforms Sales Value (2019-2030) & (US$ Million)
Figure 29. South America Antibody Discovery Platforms Sales Value by Country (%), 2023 VS 2030
Figure 30. Middle East & Africa Antibody Discovery Platforms Sales Value (2019-2030) & (US$ Million)
Figure 31. Middle East & Africa Antibody Discovery Platforms Sales Value by Country (%), 2023 VS 2030
Figure 32. Key Countries/Regions Antibody Discovery Platforms Sales Value (%), (2019-2030)
Figure 33. United States Antibody Discovery Platforms Sales Value, (2019-2030) & (US$ Million)
Figure 34. United States Antibody Discovery Platforms Sales Value by Type (%), 2023 VS 2030
Figure 35. United States Antibody Discovery Platforms Sales Value by Application (%), 2023 VS 2030
Figure 36. Europe Antibody Discovery Platforms Sales Value, (2019-2030) & (US$ Million)
Figure 37. Europe Antibody Discovery Platforms Sales Value by Type (%), 2023 VS 2030
Figure 38. Europe Antibody Discovery Platforms Sales Value by Application (%), 2023 VS 2030
Figure 39. China Antibody Discovery Platforms Sales Value, (2019-2030) & (US$ Million)
Figure 40. China Antibody Discovery Platforms Sales Value by Type (%), 2023 VS 2030
Figure 41. China Antibody Discovery Platforms Sales Value by Application (%), 2023 VS 2030
Figure 42. Japan Antibody Discovery Platforms Sales Value, (2019-2030) & (US$ Million)
Figure 43. Japan Antibody Discovery Platforms Sales Value by Type (%), 2023 VS 2030
Figure 44. Japan Antibody Discovery Platforms Sales Value by Application (%), 2023 VS 2030
Figure 45. South Korea Antibody Discovery Platforms Sales Value, (2019-2030) & (US$ Million)
Figure 46. South Korea Antibody Discovery Platforms Sales Value by Type (%), 2023 VS 2030
Figure 47. South Korea Antibody Discovery Platforms Sales Value by Application (%), 2023 VS 2030
Figure 48. Southeast Asia Antibody Discovery Platforms Sales Value, (2019-2030) & (US$ Million)
Figure 49. Southeast Asia Antibody Discovery Platforms Sales Value by Type (%), 2023 VS 2030
Figure 50. Southeast Asia Antibody Discovery Platforms Sales Value by Application (%), 2023 VS 2030
Figure 51. India Antibody Discovery Platforms Sales Value, (2019-2030) & (US$ Million)
Figure 52. India Antibody Discovery Platforms Sales Value by Type (%), 2023 VS 2030
Figure 53. India Antibody Discovery Platforms Sales Value by Application (%), 2023 VS 2030
Figure 54. Antibody Discovery Platforms Industrial Chain
Figure 55. Antibody Discovery Platforms Manufacturing Cost Structure
Figure 56. Channels of Distribution (Direct Sales, and Distribution)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation

Our Clients